Загрузка...
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
BACKGROUND: The efficacy of ertugliflozin, a sodium–glucose cotransporter 2 inhibitor, for glycemic and blood pressure (BP) control has been demonstrated in phase 3 studies. To further evaluate the effects of ertugliflozin on BP and other hemodynamic parameters, an analysis was conducted on the pool...
Сохранить в:
| Опубликовано в: : | Cardiovasc Diabetol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503446/ https://ncbi.nlm.nih.gov/pubmed/31064361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0856-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|